Contact Person : David Drey; Last Date for the submission of abstract : Not Available ; Description : This cevent will address potential regulatory changes in the PMA and 510(k) submission and approval processes and provide regulatory affairs executives knowledge on how to streamline their submission process by anticipating FDA requirements